Integrating hypertension screening at the time of voluntary HIV testing among adults in South Africa.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 30 03 2018
accepted: 18 12 2018
entrez: 9 2 2019
pubmed: 9 2 2019
medline: 30 10 2019
Statut: epublish

Résumé

Guidelines recommend integrating hypertension screening for HIV-infected adults, but blood pressure measurements may be dynamic around the time of HIV testing. We measured a seated resting blood pressure in adults (≥18 years) prior to HIV testing, and again after receiving HIV test results, in an ambulatory HIV clinic in KwaZulu-Natal, South Africa. We assessed sociodemographics, smoking, body mass index, diabetes, substance abuse, and anxiety/depression. We used blood pressure categories defined by the Seventh Joint National Committee (JNC 7) classifications, which includes normal, pre-hypertension, stage 1 hypertension, and stage 2 hypertension. Among 5,428 adults, mean age was 31 years, 51% were male, and 35% tested HIV-positive. Before HIV testing, 47% (2,634) had a normal blood pressure, 40% (2,225) had prehypertension, and 10% (569) had stage 1 or 2 hypertension. HIV-infected adults had significantly lower blood pressure measurements and less hypertension, as compared to HIV-negative adults before HIV testing; while also having significantly elevated blood pressures after HIV testing. In a multivariable model, HIV-infected adults had a 30% lower odds of hypertension, compared to HIV-uninfected adults (aOR = 0.70, 95% CI: 0.57-0.85). In a separate multivariable model, HIV-infected adults with CD4 ≤200 cells/mm3 had a 44% lower odds of hypertension (aOR = 0.56, 95% CI: 0.38-0.83), as compared to adults with CD4 >200 cells/mm3. The mean arterial blood pressure was 6.5 mmHg higher among HIV-infected adults after HIV testing (p <0.001). HIV-infected adults experienced a transient blood pressure increase after receiving HIV results. Blood pressure measurements may be more accurate before HIV testing and repeated blood pressure measurements are recommended after ART initiation before formally diagnosing hypertension in HIV-infected adults.

Sections du résumé

BACKGROUND
Guidelines recommend integrating hypertension screening for HIV-infected adults, but blood pressure measurements may be dynamic around the time of HIV testing.
METHODS
We measured a seated resting blood pressure in adults (≥18 years) prior to HIV testing, and again after receiving HIV test results, in an ambulatory HIV clinic in KwaZulu-Natal, South Africa. We assessed sociodemographics, smoking, body mass index, diabetes, substance abuse, and anxiety/depression. We used blood pressure categories defined by the Seventh Joint National Committee (JNC 7) classifications, which includes normal, pre-hypertension, stage 1 hypertension, and stage 2 hypertension.
RESULTS
Among 5,428 adults, mean age was 31 years, 51% were male, and 35% tested HIV-positive. Before HIV testing, 47% (2,634) had a normal blood pressure, 40% (2,225) had prehypertension, and 10% (569) had stage 1 or 2 hypertension. HIV-infected adults had significantly lower blood pressure measurements and less hypertension, as compared to HIV-negative adults before HIV testing; while also having significantly elevated blood pressures after HIV testing. In a multivariable model, HIV-infected adults had a 30% lower odds of hypertension, compared to HIV-uninfected adults (aOR = 0.70, 95% CI: 0.57-0.85). In a separate multivariable model, HIV-infected adults with CD4 ≤200 cells/mm3 had a 44% lower odds of hypertension (aOR = 0.56, 95% CI: 0.38-0.83), as compared to adults with CD4 >200 cells/mm3. The mean arterial blood pressure was 6.5 mmHg higher among HIV-infected adults after HIV testing (p <0.001).
CONCLUSIONS
HIV-infected adults experienced a transient blood pressure increase after receiving HIV results. Blood pressure measurements may be more accurate before HIV testing and repeated blood pressure measurements are recommended after ART initiation before formally diagnosing hypertension in HIV-infected adults.

Identifiants

pubmed: 30735518
doi: 10.1371/journal.pone.0210161
pii: PONE-D-18-09681
pmc: PMC6368277
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0210161

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI108293
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI110264
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2007 Apr 26;356(17):1723-35
pubmed: 17460226
HIV Med. 2009 Sep;10(8):496-503
pubmed: 19486188
Prev Chronic Dis. 2012;9:E93
pubmed: 22554408
Braz J Infect Dis. 2010 May-Jun;14(3):281-7
pubmed: 20835513
PLoS One. 2016 May 27;11(5):e0156309
pubmed: 27232186
PLoS One. 2016 Feb 10;11(2):e0148100
pubmed: 26862763
Circulation. 2005 Feb 8;111(5):697-716
pubmed: 15699287
BMC Public Health. 2015 Feb 12;15:135
pubmed: 25885455
Pan Afr Med J. 2009 Oct 24;3:10
pubmed: 21532719
N Engl J Med. 2005 Jan 6;352(1):48-62
pubmed: 15635112
JACC Heart Fail. 2015 Aug;3(8):591-9
pubmed: 26164679
Am J Hypertens. 2005 Nov;18(11):1396-401
pubmed: 16280270
J Am Soc Hypertens. 2015 May;9(5):403-7
pubmed: 25979413
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
J Hypertens. 2003 Nov;21(11):1983-92
pubmed: 14597836
J Hum Hypertens. 2016 Jun;30(6):355-62
pubmed: 26446389
AIDS Patient Care STDS. 2016 Jan;30(1):4-10
pubmed: 26683587
JAMA. 2003 May 21;289(19):2560-72
pubmed: 12748199
HIV Med. 2016 Jun;17(6):411-24
pubmed: 26611380
Lancet. 2015 Jan 10;385(9963):117-71
pubmed: 25530442
Int J Epidemiol. 2013 Dec;42(6):1754-71
pubmed: 24415610
HIV Med. 2008 Feb;9(2):72-81
pubmed: 18257770
Clin Infect Dis. 2016 Jul 15;63(2):242-8
pubmed: 27090989
J Clin Hypertens (Greenwich). 2013 Feb;15(2):101-6
pubmed: 23339727
Int J Hypertens. 2016;2016:5958382
pubmed: 27872756
J Hypertens. 2015 Oct;33(10):2039-45
pubmed: 26431192
AIDS. 2018 Jul 1;32 Suppl 1:S1-S3
pubmed: 29952785
Neurology. 2016 Jan 26;86(4):324-33
pubmed: 26683649
Int J Epidemiol. 2014 Feb;43(1):116-28
pubmed: 24505082
J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12
pubmed: 17456578
Cardiovasc Diagn Ther. 2015 Dec;5(6):420-7
pubmed: 26675421
Cardiovasc J Afr. 2014 Nov-Dec;25(6):288-94
pubmed: 25629715
J Int AIDS Soc. 2017 Oct;20(2):
pubmed: 29064168
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941

Auteurs

Paul K Drain (PK)

Department of Global Health, University of Washington, Seattle, United States of America.
Department of Medicine, University of Washington, Seattle, United States of America.
Department of Epidemiology, University of Washington, Seattle, United States of America.

Ting Hong (T)

Department of Global Health, University of Washington, Seattle, United States of America.

Anjum Hajat (A)

Department of Epidemiology, University of Washington, Seattle, United States of America.

Meighan Krows (M)

Department of Global Health, University of Washington, Seattle, United States of America.

Sabina Govere (S)

AIDS Healthcare Foundation, Durban, South Africa.

Hilary Thulare (H)

AIDS Healthcare Foundation, Durban, South Africa.

Mahomed Yunus S Moosa (MYS)

Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.

Ingrid Bassett (I)

Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, United States of America.

Connie Celum (C)

Department of Global Health, University of Washington, Seattle, United States of America.
Department of Medicine, University of Washington, Seattle, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH